Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Gibco™ Viral-Plex™ Complexation Buffer

Catalog No. A4983901
Encompass_Preferred
Click to view available options
Quantity:
100 mL

A chemically defined, protein-free, phenol red-free buffer for complexing plasmid DNA with transfection reagent for standard transfection applications.

Gibco Viral-Plex Complexation Buffer is a ready-to-use AAV production buffer and complexation reagent for gene therapy, formulated to efficiently complex plasmid DNA with lipid-based transfection reagents for viral vector manufacturing. This chemically defined, serum- and protein-free buffer provides an optimal environment for forming stable DNA/lipid complexes, enabling efficient transient transfection of Viral Production Cells 2.0 (VPC2.0). As a key component of the AAV-MAX Production System, Viral-Plex Complexation Buffer streamlines the triple-transfection workflow for high-titer AAV production.

Features of the Viral-Plex Complexation Buffer

  • Chemically defined, animal origin–free formulation—protein- and phenol red–free buffer provides a controlled environment for consistent DNA–lipid complex formation
  • Optimized for AAV workflows—designed for use with the AAV-MAX Production System to enable efficient, helper-free triple-transfection in suspension culture, streamlining gene therapy vector production
  • High-titer, scalable production—supports AAV yields greater than 5 x 1010 vg/mL (unpurified) in suspension culture; seamlessly scales from shake flasks to bioreactors for large-scale viral vector manufacturing
  • Ready-to-use solution—supplied as a 1X formulation (e.g., 100 mL bottle) requiring no preparation; mix with plasmid DNA for immediate transfection use
  • Consistent performance—a stable, pre-formulated buffer ensures reproducible transfection efficiency and batch-to-batch consistency in viral vector manufacturing

Applications

  • Gene therapy—ideal for the production of adeno-associated viral (AAV) vectors for gene therapy research and development
  • Cell therapy—supports the generation of adeno-associated viral (AAV) vectors for cell therapy applications, facilitating seamless transition from bench to clinic
  • Research and development—provides a reliable and scalable solution for viral vector production in various research settings

Available in RUO or CTS

Offered as both a Research Use Only (RUO) version and a GMP-compliant Cell Therapy Systems (CTS) version (Cat. No. A5145403) to support translational and clinical-scale applications.

TRUSTED_SUSTAINABILITY

Specifications

Cell Line HEK293
Content And Storage 100mL bottle, store at 2°C to 8°C, protected from light. Do not freeze.
Culture Type Suspension Cell Culture
Description Serum-free, animal origin-free, chemically defined, protein free, phenol red free
Cell Type Established Cell Lines
Format Bottle
Sample Type Plasmid DNA
Transfection Technique Lipid-based Transfection
Expression System Mammalian
For Use With (Equipment) AAV-MAX System
For Use With (Application) AAV Production
Includes 100 mL Gibco Viral-Plex Complexation Buffer
Product Line AAV-MAX
Product Type AAV production transfection buffer
Quantity 100 mL
Reagent Type Transfection buffer
Shipping Condition Wet Ice
Sterility Sterile
Show More Show Less
WARNING: Reproductive Harm - www.P65Warnings.ca.gov

For Research Use Only. Not for use in diagnostic procedures.

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.